A new treatment is effective for advanced HER2-low breast cancer
Treatment with trastuzumab deruxtecan, a combination of a targeted therapy with chemotherapy, increases progression-free survival of the disease and1
Treatment with trastuzumab deruxtecan, a combination of a targeted therapy with chemotherapy, increases progression-free survival of the disease and1
The Hospital Clínic de Barcelona, through the Urology Service, led by Dr. Antonio Alcaraz has started to perform surgeries to reverse male infertilit1
Researchers from the Hospital Clínic-IDIBAPS, IDIBELL and CIBERSAM have developed a smartphone app that allows anxiety to be assessed continuously an1
The Hospital Clínic de Barcelona is consolidating its transorbital surgery programme for patients with skull base tumours. This surgery is led by the1
The study, led by researchers from Hospital Clínic-IDIBAPS, will be a paradigm shift in the treatment of the disease worldwide
The published results show that six months after implementation, 64% of patients had optimal heart function and that the pacing corrects cardiac asyn1
The finding may make it possible to take therapeutic approaches that will increase the success rate of cognitive-behavioral therapy. This is the ther1
The new test, called HER2DX, analyzes RNA on 27 genes to predict survival outcomes and the likelihood that patients will respond to treatment.
The Hospital Clínic de Barcelona has incorporated a new robot to improve the detection of skin cancer. It is the Vectra WB360, a device that combines1
The Hospital Clínic-IDIBAPS has developed the first CAR T-cell therapy in Europe to treat multiple myeloma, the second most common type of blood canc1